The fundamental distinction between negative and positive rights is essential to ... No one would draw those distinctions. And the same logic should apply here. If viewpoint discrimination is ...

(“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported ...

The positive preliminary SENTI-202 clinical ... consistent with the SENTI-202 Logic Gated gene circuit’s designed mechanism of action.

The positive preliminary SENTI-202 clinical ... consistent with the SENTI-202 Logic Gated gene circuit’s designed mechanism of action. Safety SENTI-202 is generally well tolerated with an ...

("Senti Bio” or the "Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported positive initial ...